A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine

Clinical trial NCT05239806 · UNKNOWN

Trial details

NCT number: NCT05239806
Sponsor: Sinocelltech Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 SARS-CoV-2 Infection

Start date: 2022-04-01
Primary completion: 2022-08-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.